ML-12 HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (HDC-ASCT) FOR THE PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

High-dose chemotherapy and autologous stem-cell transplantation (HDC-ASCT) for the patient with primary central nervous system lymphoma (PCNSL) has been used as treatment at relapse or as consolidation therapy. We report on the efficacy, safety, and future issues of HDC-ASCT. Twelve patients with PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyakita, Yasuji, Inamoto, Yoshihiro, Ohno, Makoto, Takahashi, Masamichi, Yanagisawa, Shunsuke, Kawaguchi, Yuki, Mukai, Takayuki, Masaki, Yasufumi, Fukuda, Takahiro, Narita, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719300/
http://dx.doi.org/10.1093/noajnl/vdac167.082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719300/
http://dx.doi.org/10.1093/noajnl/vdac167.082

Ejemplares similares